These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9. Deng L; Fan J; Guo M; Huang B Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055 [TBL] [Abstract][Full Text] [Related]
4. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation. Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846 [No Abstract] [Full Text] [Related]
5. A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer. Marelli G; Chard Dunmall LS; Yuan M; Di Gioia C; Miao J; Cheng Z; Zhang Z; Liu P; Ahmed J; Gangeswaran R; Lemoine N; Wang Y J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33500259 [TBL] [Abstract][Full Text] [Related]
6. A new oncolytic Ahmed J; Chard LS; Yuan M; Wang J; Howells A; Li Y; Li H; Zhang Z; Lu S; Gao D; Wang P; Chu Y; Al Yaghchi C; Schwartz J; Alusi G; Lemoine N; Wang Y J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217766 [TBL] [Abstract][Full Text] [Related]
7. Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells. Koval O; Kochneva G; Tkachenko A; Troitskaya O; Sivolobova G; Grazhdantseva A; Nushtaeva A; Kuligina E; Richter V Biomed Res Int; 2017; 2017():3620510. PubMed ID: 28951871 [TBL] [Abstract][Full Text] [Related]
8. Amplification of Oncolytic Vaccinia Virus Widespread Tumor Cell Killing by Sunitinib through Multiple Mechanisms. Kim M; Nitschké M; Sennino B; Murer P; Schriver BJ; Bell A; Subramanian A; McDonald CE; Wang J; Cha H; Bourgeois-Daigneault MC; Kirn DH; Bell JC; De Silva N; Breitbach CJ; McDonald DM Cancer Res; 2018 Feb; 78(4):922-937. PubMed ID: 29259007 [TBL] [Abstract][Full Text] [Related]
9. Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT). Zuo S; Wei M; He B; Chen A; Wang S; Kong L; Zhang Y; Meng G; Xu T; Wu J; Yang F; Zhang H; Wang S; Guo C; Wu J; Dong J; Wei J EBioMedicine; 2021 Feb; 64():103240. PubMed ID: 33581644 [TBL] [Abstract][Full Text] [Related]
10. GMCSF-armed vaccinia virus induces an antitumor immune response. Parviainen S; Ahonen M; Diaconu I; Kipar A; Siurala M; Vähä-Koskela M; Kanerva A; Cerullo V; Hemminki A Int J Cancer; 2015 Mar; 136(5):1065-72. PubMed ID: 25042001 [TBL] [Abstract][Full Text] [Related]
11. A vaccinia virus armed with interleukin-10 is a promising therapeutic agent for treatment of murine pancreatic cancer. Chard LS; Maniati E; Wang P; Zhang Z; Gao D; Wang J; Cao F; Ahmed J; El Khouri M; Hughes J; Wang S; Li X; Denes B; Fodor I; Hagemann T; Lemoine NR; Wang Y Clin Cancer Res; 2015 Jan; 21(2):405-16. PubMed ID: 25416195 [TBL] [Abstract][Full Text] [Related]
12. An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade. Zuo S; Wei M; Xu T; Kong L; He B; Wang S; Wang S; Wu J; Dong J; Wei J J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34949694 [TBL] [Abstract][Full Text] [Related]
13. The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy. de Vries CR; Monken CE; Lattime EC Cancer Gene Ther; 2015 Apr; 22(3):154-62. PubMed ID: 25633483 [TBL] [Abstract][Full Text] [Related]
14. A human immunodeficiency virus type 1 Env-granulocyte-macrophage colony-stimulating factor fusion protein enhances the cellular immune response to Env in a vaccinia virus-based vaccine. Rodr Guez D; Rodr Guez JR; Llorente M; V Zquez I; Lucas P; Esteban M; Mart Nez-A C; Del Real G J Gen Virol; 1999 Jan; 80 ( Pt 1)():217-223. PubMed ID: 9934705 [TBL] [Abstract][Full Text] [Related]
15. Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF. Choi KJ; Zhang SN; Choi IK; Kim JS; Yun CO Gene Ther; 2012 Jul; 19(7):711-23. PubMed ID: 21993173 [TBL] [Abstract][Full Text] [Related]
16. Luteolin enhances the antitumor efficacy of oncolytic vaccinia virus that harbors IL-24 gene in liver cancer cells. Wang C; Li Q; Xiao B; Fang H; Huang B; Huang F; Wang Y J Clin Lab Anal; 2021 Mar; 35(3):e23677. PubMed ID: 33274495 [TBL] [Abstract][Full Text] [Related]
17. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses. Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230 [TBL] [Abstract][Full Text] [Related]
18. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect. Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479 [TBL] [Abstract][Full Text] [Related]
19. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus. Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040 [TBL] [Abstract][Full Text] [Related]
20. Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia. Wang W; Liu S; Dai P; Yang N; Wang Y; Giese RA; Merghoub T; Wolchok J; Deng L J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34593618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]